Shapley-Quinn Mary Kate, Song Mei, Chen Beatrice A, Devlin Brid, Luecke Ellen, Brown Jill, Blithe Diana L, Achilles Sharon L, van der Straten Ariane
Women's Global Health Imperative, RTI International, Berkeley, CA, United States.
Magee-Womens Research Institute, Pittsburgh, PA, United States.
Front Reprod Health. 2023 Jul 6;5:1147628. doi: 10.3389/frph.2023.1147628. eCollection 2023.
With high concurrent global rates of HIV incidence and unintended pregnancy, there is a need to provide options beyond condoms to enable users to simultaneously prevent HIV acquisition and pregnancy. Multiple vaginal rings are in development as "MPTs" (multipurpose prevention technologies) as they are shown to provide several co-occurring benefits such as discretion, convenience, reversibility and user control.
In this Phase 1 trial of a 3-month MPT ring in the U.S., 25 participants (low-risk for HIV and pregnancy) were randomized to use the study ring for 90 days continuously or in 28-day cycles with 2-day removal periods in between. All participants completed in-depth interviews at the end of their study participation.
Overall, the ring was well tolerated. Participants resoundingly endorsed the concept of an extended-use, dual-purpose vaginal ring, but reported too many functional challenges and side effects to endorse this particular ring. Participants assigned to the continuous regimen reported more positive experiences with ring use than those in the cyclic group. A minority of participants who experienced minimal side effects and did not experience challenges with vaginal retention of the ring found it appealing. However, the majority of participants experienced challenges (ring slippage, expulsions, side effects, vaginal bleeding changes) with product use that outweighed the potential benefits and led them to report that - in the future - they would not be interested in using this specific version of the ring in its current form. A subset expressed interest in using the current MPT ring under certain conditions (e.g., if fewer expulsions, less bleeding, higher risk for HIV/pregnancy).
User feedback regarding participant experiences and challenges with the study ring was continuously shared with the product developer, underscoring the value of early-stage end-user feedback in product development.
鉴于全球艾滋病毒感染率和意外怀孕率居高不下,需要提供避孕套以外的选择,以便使用者能够同时预防艾滋病毒感染和怀孕。多种阴道环正在作为“多用途预防技术”(MPT)进行研发,因为它们显示出具有多种共同的益处,如隐秘性、便利性、可逆性和使用者可控性。
在美国进行的这项为期3个月的MPT环1期试验中,25名参与者(艾滋病毒和怀孕低风险)被随机分配,连续90天或按28天周期使用研究用环,中间有2天的取出期。所有参与者在研究结束时都完成了深度访谈。
总体而言,该环耐受性良好。参与者一致认可延长使用的两用阴道环的概念,但报告了太多功能挑战和副作用,无法认可这一特定的环。分配到连续使用方案的参与者报告使用环的体验比周期组更积极。少数副作用最小且未遇到环在阴道内留存问题的参与者觉得它很有吸引力。然而,大多数参与者在使用产品时遇到了挑战(环滑落、排出、副作用、阴道出血变化),这些挑战超过了潜在益处,导致他们报告说,未来他们不会对以当前形式使用这种特定版本的环感兴趣。一部分人表示在某些条件下(例如,排出次数减少、出血减少、艾滋病毒/怀孕风险更高)有兴趣使用当前的MPT环。
关于参与者对研究用环的体验和挑战的用户反馈不断与产品开发者分享,突出了早期终端用户反馈在产品开发中的价值。